Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-01 Tax Withholding |
2023-02-03 5:02 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
36 | $3.52 | 20,294 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:02 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
12,000 | $0 | 20,294 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:02 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
1,000 | $3.52 | 20,294 (Direct) |
View |
| 2022-09-01 Tax Withholding |
2022-09-06 4:55 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
570 | $8.53 | 7,330 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:35 pm |
N/A 2032-01-31 |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
5,000 | $0 | 12,900 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:35 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
400 | $10.02 | 12,900 (Direct) |
View |
Ownership |
2021-09-02 6:39 pm |
N/A N/A |
LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer |
0 | $0 | 50,000 (Direct) |
View |